AgeneBio's Seed Round

AgeneBio raised a round of funding on May 07, 2010. Investors include BioCrossroads.

AgeneBio is developing therapies for people who have Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's disease (AD). The company has a new clinical strategy to help address the therapeutic nee…

Articles about AgeneBio's Seed Round: